{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:49:51Z","timestamp":1773298191642,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.msard.2018.11.022","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T12:20:26Z","timestamp":1542716426000},"page":"383-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal"],"prefix":"10.1016","volume":"27","author":[{"given":"Laura","family":"Weinkle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1075-5389","authenticated-orcid":false,"given":"Christopher H.","family":"Domen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Sillau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2018.11.022_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fpls.2016.00019","article-title":"Cannabis sativa: the plant of the thousand and one molecules","volume":"7","author":"Andre","year":"2016","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.msard.2018.11.022_bib0002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2045125312457586","article-title":"Cannabis, a complex plant: different compounds and different effects on individuals","volume":"2","author":"Atakan","year":"2012","journal-title":"Therapeut. Adv. Psychopharmacol."},{"key":"10.1016\/j.msard.2018.11.022_bib0003","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.msard.2016.09.008","article-title":"Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis","volume":"10","author":"Banwell","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2018.11.022_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7400","article-title":"Treatments for spasticity and pain in multiple sclerosis: a systematic review","volume":"7","author":"Beard","year":"2003","journal-title":"Health Technol. Assess"},{"key":"10.1016\/j.msard.2018.11.022_bib0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13722-015-0032-7","article-title":"Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders","volume":"10","author":"Belendiuk","year":"2015","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.msard.2018.11.022_bib0006","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/npp.2017.209","article-title":"Clinical and preclinical evidence for functional interactions of cannabidiol and \u03949-tetrahydrocannabinol","volume":"43","author":"Boggs","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.msard.2018.11.022_bib0007","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","article-title":"Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress","volume":"51","author":"Booz","year":"2011","journal-title":"Free Radical Bio. Med."},{"key":"10.1016\/j.msard.2018.11.022_bib0008","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00415-017-8715-5","article-title":"Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis","volume":"265","author":"Brenton","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2018.11.022_bib0009","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/1352458506070947","article-title":"Cannabis use in patients with multiple sclerosis","volume":"12","author":"Chong","year":"2006","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2018.11.022_bib0010","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1212\/01.WNL.0000127707.07621.72","article-title":"Patterns of cannabis use among patients with multiple sclerosis","volume":"62","author":"Clark","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.11.022_bib0011","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1212\/CPJ.0000000000000383","article-title":"Perspectives on marijuana use and effectiveness: a survey of NARCOMS participants","volume":"7","author":"Cofield","year":"2017","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.msard.2018.11.022_bib0012","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000112901","article-title":"The perceived effects of smoked cannabis on patients with multiple sclerosis","volume":"38","author":"Consroe","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.msard.2018.11.022_bib0013","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1503\/cmaj.110837","article-title":"Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial","volume":"184","author":"Corey-Bloom","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.msard.2018.11.022_bib0014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.msard.2018.11.022_bib0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1176\/jnp.15.1.98","article-title":"Effects of depressed mood on objective and subjective measures of attention","volume":"15","author":"Farrin","year":"2003","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.msard.2018.11.022_bib0016","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/CPJ.0000000000000162","article-title":"Clinical perspectives on medical marijuana (cannabis) for neurologic disorders","volume":"5","author":"Fife","year":"2015","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.msard.2018.11.022_bib0017","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/0269215517745348","article-title":"A mixed treatment comparison on efficacy and safety of treatments for spasticity caused by multiple sclerosis: a systematic review and network meta-analysis","volume":"32","author":"Fu","year":"2018","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.msard.2018.11.022_bib0018","doi-asserted-by":"crossref","first-page":"18781","DOI":"10.3390\/molecules191118781","article-title":"Cannabinoids: new promising agents in the treatment of neurological diseases","volume":"19","author":"Giacoppo","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.msard.2018.11.022_bib0019","article-title":"Marijuana Usage by Multiple Sclerosis Patients","author":"Gupta","year":"2018","journal-title":"Int. J. MS Care"},{"issue":"7","key":"10.1016\/j.msard.2018.11.022_bib0020","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items","volume":"18","author":"Hays","year":"2009","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.msard.2018.11.022_bib0021","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","article-title":"Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the guideline development subcommittee of the American academy of neurology","volume":"82","author":"Koppel","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.11.022_bib0022","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2377-13-37","article-title":"Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis","volume":"13","author":"Learmonth","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2018.11.022_bib0023","doi-asserted-by":"crossref","first-page":"139","DOI":"10.7224\/1537-2073-5.4.139","article-title":"Perceived effects of marijuana use by MS patients in Saskatchewan\u2014A pilot study","volume":"5","author":"Linassi","year":"2003","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.msard.2018.11.022_bib0024","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugpo.2017.01.011","article-title":"Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients","volume":"42","author":"Lucas","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.msard.2018.11.022_bib0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]","volume":"197","author":"Morgan","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.msard.2018.11.022_bib0027","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S0317167100002584","article-title":"Cannabis use as described by people with multiple sclerosis","volume":"30","author":"Page","year":"2003","journal-title":"Can J. Neurol. Sci."},{"key":"10.1016\/j.msard.2018.11.022_bib0028","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11910-018-0859-x","article-title":"Cannabinoids for treatment of MS symptoms: state of the evidence","volume":"18","author":"Rice","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.msard.2018.11.022_bib0029","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/arclin\/17.3.205","article-title":"Depressive symptoms and neurocognitive test scores in patients passing symptom validity tests","volume":"17","author":"Rohling","year":"2002","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.msard.2018.11.022_bib0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nicl.2015.04.006","article-title":"Multiple sclerosis, cannabis, and cognition: A structural MRI study","volume":"8","author":"Romero","year":"2015","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.msard.2018.11.022_bib0031","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fneur.2017.00299","article-title":"Cannabis and Multiple Sclerosis-the way forward","volume":"8","author":"Rudroff","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2018.11.022_bib0032","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/a0029117","article-title":"Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis","volume":"20","author":"Schreiner","year":"2012","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.msard.2018.11.022_bib0033","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.88.16_supplement.P3.356","article-title":"Use of medical Marijuana for the relief of Multiple Sclerosis (MS) symptoms in a community cohort: survey from the Pacific Northwest MS registry (P30.356)","volume":"88","author":"Stuchiner","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.11.022_bib0034","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","article-title":"Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial","volume":"329","author":"Svendsen","year":"2004","journal-title":"Bmj"},{"key":"10.1016\/j.msard.2018.11.022_bib0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of Multiple Sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.msard.2018.11.022_bib0036","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1001\/jama.2015.6613","article-title":"Cannabinoid Dose and label accuracy in edible medical cannabis products","volume":"313","author":"Vandrey","year":"2015","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.msard.2018.11.022_bib0037","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2018.11.022_bib0038","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/1352458505070618","article-title":"Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis","volume":"12","author":"Wade","year":"2006","journal-title":"Mult. Scler"},{"key":"10.1016\/j.msard.2018.11.022_bib0039","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/11539000-000000000-00000","article-title":"Role of cannabinoids in multiple sclerosis","volume":"25","author":"Zajicek","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.msard.2018.11.022_bib0040","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/jnnp.2005.070136","article-title":"Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up","volume":"76","author":"Zajicek","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818305157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818305157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:47:43Z","timestamp":1761900463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034818305157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":39,"alternative-id":["S2211034818305157"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.11.022","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}